Ameriprise
NGVT icon

Ameriprise’s Ingevity NGVT Stock Holding History

Ameriprise’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Sell
171,321
-12,023
-7% -$822K ﹤0.01% 1779
2025
Q4 		$10.9M Sell
183,344
-3,185
-2% -$173K ﹤0.01% 1847
2025
Q3 		$10.3M Sell
186,529
-20,909
-10% -$1.09M ﹤0.01% 1884
2025
Q2 		$8.94M Buy
207,438
+764
+0.4% +$29.5K ﹤0.01% 1904
2025
Q1 		$8.18M Sell
206,674
-17,525
-8% -$776K ﹤0.01% 1912
2024
Q4 		$9.14M Buy
224,199
+2,810
+1% +$117K ﹤0.01% 1871
2024
Q3 		$8.63M Buy
221,389
+14,057
+7% +$560K ﹤0.01% 1925
2024
Q2 		$9.06M Sell
207,332
-10,707
-5% -$517K ﹤0.01% 1828
2024
Q1 		$10.4M Buy
218,039
+80,161
+58% +$3.6M ﹤0.01% 1743
2023
Q4 		$6.51M Sell
137,878
-13,196
-9% -$548K ﹤0.01% 2143
2023
Q3 		$7.19M Sell
151,074
-1,259
-0.8% -$68.7K ﹤0.01% 1989
2023
Q2 		$8.86M Buy
152,333
+73,629
+94% +$4.42M ﹤0.01% 1877
2023
Q1 		$5.63M Buy
78,704
+1,465
+2% +$116K ﹤0.01% 2239
2022
Q4 		$5.44M Sell
77,239
-3,970
-5% -$280K ﹤0.01% 2229
2022
Q3 		$4.92M Buy
81,209
+15,470
+24% +$1.04M ﹤0.01% 2235
2022
Q2 		$4.15M Buy
65,739
+6,976
+12% +$455K ﹤0.01% 2413
2022
Q1 		$3.77M Sell
58,763
-4,440
-7% -$297K ﹤0.01% 2607
2021
Q4 		$4.53M Sell
63,203
-2,381
-4% -$181K ﹤0.01% 2538
2021
Q3 		$4.68M Sell
65,584
-5,644
-8% -$445K ﹤0.01% 2436
2021
Q2 		$5.79M Sell
71,228
-5,046
-7% -$406K ﹤0.01% 2350
2021
Q1 		$5.76M Sell
76,274
-2,364
-3% -$172K ﹤0.01% 2313
2020
Q4 		$5.96M Sell
78,638
-7,604
-9% -$495K ﹤0.01% 2149
2020
Q3 		$4.26M Sell
86,242
-4,670
-5% -$264K ﹤0.01% 2198
2020
Q2 		$4.78M Buy
90,912
+1,973
+2% +$93.6K ﹤0.01% 2098
2020
Q1 		$3.13M Sell
88,939
-135,989
-60% -$7.94M ﹤0.01% 2227
2019
Q4 		$19.7M Sell
224,928
-9,645
-4% -$843K 0.01% 1216
2019
Q3 		$19.9M Buy
234,573
+56,268
+32% +$5.01M 0.01% 1143
2019
Q2 		$18.8M Sell
178,305
-605
-0.3% -$60.8K 0.01% 1215
2019
Q1 		$18.9M Sell
178,910
-85,092
-32% -$8.55M 0.01% 1187
2018
Q4 		$22.1M Sell
264,002
-5,202
-2% -$471K 0.01% 1005
2018
Q3 		$27.4M Buy
269,204
+20,342
+8% +$1.96M 0.01% 1079
2018
Q2 		$20.1M Sell
248,862
-23,910
-9% -$1.9M 0.01% 1167
2018
Q1 		$20.1M Sell
272,772
-17,528
-6% -$1.31M 0.01% 1114
2017
Q4 		$20.5M Sell
290,300
-10,214
-3% -$737K 0.01% 1050
2017
Q3 		$18.8M Buy
300,514
+13,448
+5% +$796K 0.01% 1087
2017
Q2 		$16.5M Sell
287,066
-91,944
-24% -$5.41M 0.01% 1170
2017
Q1 		$23.1M Buy
379,010
+156,578
+70% +$8.86M 0.01% 915
2016
Q4 		$12.2M Buy
222,432
+2,723
+1% +$131K 0.01% 1366
2016
Q3 		$10.1M Buy
219,709
+4,265
+2% +$180K 0.01% 1441
2016
Q2 		$7.33M Buy
+215,444
New +$6.73M ﹤0.01% 1646

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

Ameriprise's NGVT Position: Q1 2026 in Review

Ameriprise reduced its Ingevity (NGVT) stake by 6.6% in Q1 2026, selling an estimated $822K and leaving 171,321 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

Ameriprise first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $27.4M in Q3 2018. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Ameriprise held 171,321 shares of Ingevity worth $12.2M as of Q1 2026.
  • Ameriprise sold 12,023 Ingevity shares in Q1 2026, an estimated $822K.
  • Ingevity made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1779 holding.
  • Ameriprise first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
  • Ameriprise's Ingevity position peaked at $27.4M in Q3 2018.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.